Archive · 5 Dec 2025
India Mandates QR Codes on Emergency Contraceptives
India's drug regulator is making a new rule for emergency contraceptive pills.
These pills, like Unwanted-72 and i-pill, will now have QR codes on their packaging.
When you scan the QR code, it will show important information about the medicine, like how to take it, possible side effects, and warnings.
The main warnings say these pills should not be used more than twice a month and do not protect against sexually transmitted infections.
Experts say this will help women use these pills safely and correctly.
The rule is part of a bigger effort to make sure people have the right information about medicines.
Big companies that make these pills, like Mankind Pharma and Cipla, will be affected by this new rule.
India's DCGI to mandate QR codes on emergency contraceptive packaging.
QR codes will provide detailed drug information and safety warnings.
Pills should not be used more than twice a month and do not protect against STIs.
Measure aims to prevent misuse and ensure safe usage.
Affects major manufacturers like Mankind Pharma and Cipla in India's $1.7 billion contraceptive market.
- Who
- Drugs Controller General of India (DCGI)
- What
- Mandating QR codes on emergency contraceptive packaging
- When
- Implementation details not specified
- Where
- India
- Why
- To prevent misuse and ensure access to safety information
- Regulator
- Drugs Controller General of India (DCGI)
- Purpose
- Prevent misuse, ensure safety information access
- QR Code Content
- Dosage, contraindications, side effects, storage, counselling
- Warnings
- Not for STI protection, max 2 uses/month
- Market Impact
- Affects $1.7 billion contraceptive market
- Key Manufacturers
- Mankind Pharma, Piramal Pharma, Cipla, Hindustan Lifecare
- Expert Opinion
- Dr. Archana Dhawan Bajaj, Poonam Muttreja